title: Treatment guidelines for adjuvant breast cancer are moving toward double standards: one for the rich and one for the poor.
authors.forename: Gaston
authors.initials: G
authors.lastname: Demonty
mesh_terms: D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000191:economics* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000191:economics*; D017024:Chemotherapy, Adjuvant; D003657:Decision Making; D003906:Developing Countries; D018572:Disease-Free Survival; D016527:Drug Costs; D005260:Female; D006801:Humans; D009570:Nitriles / Q000191:economics* / Q000627:therapeutic use; D013629:Tamoxifen / Q000191:economics / Q000627:therapeutic use; D014230:Triazoles / Q000191:economics* / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014230:Triazoles; D013629:Tamoxifen; D000077384:Anastrozole